860518P
C18 Ceramide (d18:1/18:0)
Manufacturer: Sigma Aldrich
CAS Number: 2304-81-6
Synonym(S): N-stearoyl-D-erythro-sphingosine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 5 MG | 860518P-5-MG | In Stock | ₹ 11,073.98 |
| 10 MG | 860518P-10-MG | In Stock | ₹ 20,805.65 |
860518P - 5 MG
In Stock
Quantity
1
Base Price: ₹ 11,073.98
GST (18%): ₹ 1,993.316
Total Price: ₹ 13,067.296
form
powder
packaging
pkg of 1 × 10 mg (860518P-10mg)pkg of 1 × 5 mg (860518P-5mg)
manufacturer/tradename
Avanti Polar Lipids
lipid type
sphingolipids
shipped in
dry ice
storage temp.
−20°C
SMILES string
OC[C@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC
InChI
1S/C36H71NO3/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-36(40)37-34(33-38)35(39)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h29,31,34-35,38-39H,3-28,30,32-33H2,1-2H3,(H,37,40)/b31-29+/t34-,35+/m0/s1
InChI key
VODZWWMEJITOND-NXCSZAMKSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | eMolecules Broadpharm / C18 Ceramide / 5mg / 779523938 / BP-28817 / / 2304-81-6 / MFCD02259139 / 565.968 / C36H71NO3 | eMolecules | ₹ 18,891.65 | |
 | Avanti Polar Lipids N-octadecanoylsphingosine | 2304-81-6 | 566.0 g/mol | This is the quantity of the product sold per package. This might be represented as a volume or weight. | Avanti Polar Lipids | ₹ 18,624.70 | |
 | N-Stearoyl-D-sphingosine | Sigma Aldrich | ₹ 34,261.13 | |
 | 2304-81-6 | N-Stearoyl-D-Sphingosine | A2B Chem | ₹ 4,106.88 - ₹ 23,272.32 |
Related Products
Description
- General description: C18 Ceramide (d18:1/18:0) synthesis is catalyzed by ceramide synthase (CERS) 1 and 5. It is a component of cellular membrane and has low gel forming ability compared to unsaturated ceramide.[1]
- Application: C18 Ceramide (d18:1/18:0) has been used:to induce apoptosis in Manduca embryonic cell line (MRRL-CH1)[2]as a standard to quantify ceramide from liver tissue using liquid chromatography-mass spectrometry[3]to inhibit ceramidase in human embryonic kidney cells (HEK29) with β-glucocerebrosidase (GCase) mutation[4]
- Biochem/physiol Actions: C18 Ceramide based derivatives are present in low levels during neurodegeneration. It favors endoplasmic reticulum based stress and autophagy in glioma cells.[5] Low levels of C18-ceramide are implicated in human head and neck squamous cell carcinoma. C18 ceramide may inhibit tumor progression.[6]
- Packaging: 5 mL Amber Glass Screw Cap Vial (860518P-10mg)
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
form: powder
packaging: pkg of 1 × 10 mg (860518P-10mg)pkg of 1 × 5 mg (860518P-5mg)
manufacturer/tradename: Avanti Polar Lipids
lipid type: sphingolipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: OC[C@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC
InChI: 1S/C36H71NO3/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-36(40)37-34(33-38)35(39)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h29,31,34-35,38-39H,3-28,30,32-33H2,1-2H3,(H,37,40)/b31-29+/t34-,35+/m0/s1
InChI key: VODZWWMEJITOND-NXCSZAMKSA-N
form:
powder
packaging:
pkg of 1 × 10 mg (860518P-10mg)pkg of 1 × 5 mg (860518P-5mg)
manufacturer/tradename:
Avanti Polar Lipids
lipid type:
sphingolipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
OC[C@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC
InChI:
1S/C36H71NO3/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-36(40)37-34(33-38)35(39)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h29,31,34-35,38-39H,3-28,30,32-33H2,1-2H3,(H,37,40)/b31-29+/t34-,35+/m0/s1
InChI key:
VODZWWMEJITOND-NXCSZAMKSA-N
form: powder
packaging: pkg of 1 × 25 mg (860519P-25mg)pkg of 1 × 5 mg (860519P-5mg)
manufacturer/tradename: Avanti Polar Lipids 860519P
lipid type: sphingolipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: OC[C@]([H])(NC(CCCCCCC/C=C\CCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC
InChI: 1S/C36H69NO3/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-36(40)37-34(33-38)35(39)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,29,31,34-35,38-39H,3-16,19-28,30,32-33H2,1-2H3,(H,37,40)/b18-17-,31-29+/t34-,35+/m0/s1
InChI key: OBFSLMQLPNKVRW-RHPAUOISSA-N
form:
powder
packaging:
pkg of 1 × 25 mg (860519P-25mg)pkg of 1 × 5 mg (860519P-5mg)
manufacturer/tradename:
Avanti Polar Lipids 860519P
lipid type:
sphingolipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
OC[C@]([H])(NC(CCCCCCC/C=C\CCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC
InChI:
1S/C36H69NO3/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-36(40)37-34(33-38)35(39)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,29,31,34-35,38-39H,3-16,19-28,30,32-33H2,1-2H3,(H,37,40)/b18-17-,31-29+/t34-,35+/m0/s1
InChI key:
OBFSLMQLPNKVRW-RHPAUOISSA-N
form: powder
packaging: pkg of 1 × 5 mg (860520P-5mg)
manufacturer/tradename: Avanti Polar Lipids 860520P
lipid type: sphingolipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: OC[C@]([H])(NC(CCCCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC
InChI: 1S/C38H75NO3/c1-3-5-7-9-11-13-15-17-18-19-20-22-24-26-28-30-32-34-38(42)39-36(35-40)37(41)33-31-29-27-25-23-21-16-14-12-10-8-6-4-2/h31,33,36-37,40-41H,3-30,32,34-35H2,1-2H3,(H,39,42)/b33-31+/t36-,37+/m0/s1
InChI key: XWBWIAOWSABHFI-NUKVNZTCSA-N
form:
powder
packaging:
pkg of 1 × 5 mg (860520P-5mg)
manufacturer/tradename:
Avanti Polar Lipids 860520P
lipid type:
sphingolipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
OC[C@]([H])(NC(CCCCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC
InChI:
1S/C38H75NO3/c1-3-5-7-9-11-13-15-17-18-19-20-22-24-26-28-30-32-34-38(42)39-36(35-40)37(41)33-31-29-27-25-23-21-16-14-12-10-8-6-4-2/h31,33,36-37,40-41H,3-30,32,34-35H2,1-2H3,(H,39,42)/b33-31+/t36-,37+/m0/s1
InChI key:
XWBWIAOWSABHFI-NUKVNZTCSA-N
form: powder
packaging: pkg of 1 × 5 mg (860521P-5mg)
manufacturer/tradename: Avanti Polar Lipids 860521P
lipid type: sphingolipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@H]([C@H]1CO)O
InChI: 1S/C40H77NO8/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(43)33(32-48-40-39(47)38(46)37(45)35(31-42)49-40)41-36(44)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h27,29,33-35,37-40,42-43,45-47H,3-26,28,30-32H2,1-2H3,(H,41,44)/b29-27+/t33?,34-,35-,37+,38+,39-,40+/m1/s1
InChI key: VJLLLMIZEJJZTE-BUDJNAOESA-N
form:
powder
packaging:
pkg of 1 × 5 mg (860521P-5mg)
manufacturer/tradename:
Avanti Polar Lipids 860521P
lipid type:
sphingolipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@H]([C@H]1CO)O
InChI:
1S/C40H77NO8/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(43)33(32-48-40-39(47)38(46)37(45)35(31-42)49-40)41-36(44)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h27,29,33-35,37-40,42-43,45-47H,3-26,28,30-32H2,1-2H3,(H,41,44)/b29-27+/t33?,34-,35-,37+,38+,39-,40+/m1/s1
InChI key:
VJLLLMIZEJJZTE-BUDJNAOESA-N